Jeffrey A. Meyerhardt

Author

Also Known As

Bertagnolli, Monica M., Blanke, Charles, Hollis, Bruce W., J A Meyerhardt, J Meyerhardt, J. A. Meyerhardt, J. Meyerhardt, J.A. Meyerhardt, JEFFREY A. MEYERHARDT, Jeffrey A Meyerhardt

Publications

51.9K

Citations

115

H-Index

170

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Brigham and Women's Hospital Massachusetts General Hospital Memorial Sloan Kettering Cancer Center

About

Jeffrey A. Meyerhardt is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	113	9.5K
2	Health Sciences	29	41	3.7K
3	Public Health	23	32	2.3K
4	Biostatistics	3	3	132
5	Arts	1	1	33

Jeffrey A. Meyerhardt

373

Publications

44.4K

Citations

107

H-Index

Page 1

	Year	Citations
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Journal of the National Comprehensive Cancer Network	2021	1.7K
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer Axel Grothey, Alberto Sobrero, Anthony F. Shields, New England Journal of Medicine	2018	1.1K
Systemic Therapy for Colorectal Cancer Jeffrey A. Meyerhardt, Robert J. Mayer New England Journal of Medicine	2005	1K
<i>Fusobacterium nucleatum</i>in colorectal carcinoma tissue and patient prognosis Kosuke Mima, Reiko Nishihara, Zhi Rong Qian, Gut	2015	1K
NCCN Guidelines Insights: Colon Cancer, Version 2.2018 Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Journal of the National Comprehensive Cancer Network	2018	999
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Journal of the National Comprehensive Cancer Network	2018	979
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma Marios Giannakis, Xinmeng Jasmine Mu, Sachet A. Shukla, Cell Reports	2016	909
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer Alan P. Venook, Donna Niedzwiecki, Heinz‐Josef Lenz, JAMA	2017	852
Physical Activity and Survival After Colorectal Cancer Diagnosis Jeffrey A. Meyerhardt, Edward L. Giovannucci, Michelle D. Holmes, Journal of Clinical Oncology	2006	849
Aspirin Use, Tumor<i>PIK3CA</i>Mutation, and Colorectal-Cancer Survival Xiaoyun Liao, Paul Lochhead, Reiko Nishihara, New England Journal of Medicine	2012	825

Page 1